Aster DM Healthcare Ltd - 540975 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG Aster DM Healthcare Ltd - 540975 - Closure of Trading Window
Please be informed that in compliance with SEBI (PIT) Regulations, 2015 and the Code for Prevention of Insider Trading adopted by the Company, the Trading Window for dealing in securities of the Company shall be closed for the Designated Persons from July 01, 2024 and would be re-opened after 48 hours from the date of announcement / declaration of un-audited financial results (standalone and consolidated) of the Company for the quarter and three months ended June 30, 2024. We request you to kindly take the same on record. Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Change in Management
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 , please be informed that Mr. Farhan Yasin, Vice President - Kerala, Tamil Nadu & Retail Cluster, a Senior Management Personnel of the Company, vide his letter dated 24th June, 2024 tendered his resignation for personal reasons and has also informed that there are no other reasons for his resignation except the reason mentioned in his resignation letter. We request you to kindly take the above said information on record. Aster DM Healthcare Ltd - 540975 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Olympus Capital Asia Investments Ltd Olympus Capital Asia sells 9% stake in Aster DM Healthcare for Rs 1,530 cr
Hong Kong-based Olympus Capital Asia on Friday divested a 9 per cent stake in Hospital chain Aster DM Healthcare for Rs 1,530 crore through open market transactions. Investment firm Olympus Capital Asia, through its arm Olympus Capital Asia Investments, offloaded shares of Dubai-based Aster DM Healthcare on BSE. According to the bulk deal data available with BSE, Olympus Capital Asia Investments sold 4.50 crore shares or a 9 per cent stake in Aster DM Healthcare in two tranches. The shares were disposed of within the price range of Rs 340-340.13 apiece, taking the transaction value to Rs 1,530.08 crore. After the latest transaction, the shareholding of Olympus Capital Asia in Aster DM Healthcare has declined to 1.1 per cent from 10.1 per cent. Meanwhile, Franklin Templeton Mutual Fund, the Singapore government and Morgan Stanley Asia Singapore picked up a total of 1.24 crore shares of Aster DM Healthcare. The shares were purchased at an average price of Rs 340, taking the combine Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Investor Presentation
With reference to the captioned subject, please find enclosed presentation to be made to Investors in the upcoming investor meetings and investor conference. Request you to kindly take the above said information on record. Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Company through its representatives shall be participating in the 'Investec Investor conference' and shall be meeting various investors at Singapore on 19th June, 2024 and at Hong Kong on 20th June, 2024. We request you to kindly take the above information on record. Aster DM Healthcare Ltd - 540975 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Company through its representatives shall be participating in the 'Nuvama Investor conference' and shall be meeting various investors on June 18, 2024 at Mumbai. We request you to kindly take the above information on record. Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
This is further to our earlier letter dated May 29, 2024, regarding video/audio recordings of earning call of the Company for the quarter and year ended March 31, 2024, please find enclosed herewith the transcript of the said earnings call.